Scholarly record
ETHICAL AND LEGAL ASPECTS OF SCREENING FOR HEREDITARY DISEASES AS A SPECIAL TYPE OF MEDICAL SERVICE: A SOCIOLOGICAL ANALYSIS
Abstract
In this article, the authors review the ethical and legal aspects of screening of newborns for hereditary diseases in the context of the implementation of this medical technology as a specific medical service. In Russia, screening of newborns for phenylketonuria started in 1985, and since 1993 for congenital hypothyroidism, since 2006 - screening for cystic fibrosis, adrenogenital syndrome and galactosemia. In Russia this medical service is one of the services imposed and obligatory for all children born regardless of their place and living conditions. Purpose of the article is study of ethical and legal aspects of technologies for screening of newborns for hereditary diseases by the means of the analysis of the methodological principles of mass screening of newborns, federal and ministerial-level regulatory acts relating and regulating this technology as a public service, analysis of statistical information. The analysis revealed that for the implementation of screening and coverage of 100% of newborns, a certain algorithm and centralized organizational and methodological management of institutions that participating in screening with support from regional health authorities is used. At the same time, the legal framework regulating the screening of the fact is absent and needs to be developed taking into account positive foreign experience, the opinion of the professional medical community, as well as public opinion, especially regarding certain ethical and legal issues.
Publication Impact Profile
Publication details
References5
Tuzankina I.A., Deryabina S.S., Bolkov M.A. Primary immunodeficiencies at an early age, Moscow, pp 8-11, 2018.
Deryabina S.S. Neonatal screening for severe combined immune deficiency in Russia: a great far away or tomorrow's reality? Questions of modern pediatrics, vol. 16/issue 1, pp 60-62, 2017.
Zacharias R. L., Smith M. E., King J. S. The Legal Dimensions of Genomic Sequencing in Newborn Screening, Hastings Center Report, issue 48, pp 39-41, 2018. DOI: 10.1002/hast.884.
Johnston, J., Lantos, J. D., Goldenberg, A., Chen, F., Parens, E., Koenig, B. A., Sequencing newborns: a call for nuanced use of genomic technologies, NSIGHT Ethics and Policy Advisory Board, Hastings Center Report, vol. 48, pp 2-6, 2018. DOI: 10.1002/hast.884
Algarni M., Alolayan S., Rittenhouse B. A Systematic Review of Cost-Effectiveness Analysis Studies in Newborn Screening (NBS), Value in Health, vol. 21, pp 111-112, 2018. DOI: 10.1016/j.jval.2018.04.757.
View or Download full articleAccess options
SWS access login
Login as SWS Scientific CommitteeLogin as SWS Scientific PartnerLogin as SWS AuthorAuthors and approved SWS contributors will read and export their own linked papers after identity matching by SWS profile, email and SGEM GlobalID.
For librarian assistance: [email protected]
Purchase Instant Access
- Article can be downloaded after successful payment.
- Article may be used according to SWS library access terms.
- Article cannot be redistributed.
